Stock & Company Details
Faeth Therapeutics $FTH
Price:
N/A
N/A
26M
$496M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.13
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
FTH technical indicators
Latest Faeth Therapeutics (FTH) indicator readings as of 2026-10-29.
FTH's 14-day RSI is 35.0, in neutral territory. Price sits in the middle of its Bollinger Bands ($14.87 to $28.62). ADX reads 30.4, indicating a trending market.
Overview
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Signal:
Volatility: N/A
Sentiment:
Finance Bot
🤖
Ask your questions
Start by typing a question below.
